Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WILLOW-ACS: Low-dose vs standard aspirin with ticagrelor
NCT02741817Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in acute coronary syndrome (ACS), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jun 2016; status: completed.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02741817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741817.